Evidence map›Paper›PMID 37224318›Full record

ArticleWellcome open research2022

Interventions aiming to eliminate catastrophic costs due to tuberculosis: a protocol for a systematic review and meta-analysis.

Paula P Carballo-Jimenez, Sumona Datta, Rubén Aguirre-Ipenza, Matthew J Saunders, Luz Quevedo Cruz, Carlton A Evans

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Wellcome open research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Paula P Carballo-JimenezIFHAD: Innovation For Health And Development, Department of Infectious Disease, Imperial College London, London, UK.ORCID https://orcid.org/0000-0003-3196-4075
Sumona DattaIFHAD: Innovation For Health And Development, Department of Infectious Disease, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-3476-9753
Rubén Aguirre-IpenzaUniversidad Continental, Lima, Peru.ORCID https://orcid.org/0000-0001-9853-0824
Matthew J SaundersIFHAD: Innovation For Health And Development, Department of Infectious Disease, Imperial College London, London, UK.
Luz Quevedo CruzIFHAD: Innovation For Health And Development, Department of Infectious Disease, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-7463-3965
Carlton A EvansIFHAD: Innovation For Health And Development, Department of Infectious Disease, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-6873-5447
Universidad Peruana Cayetano Heredia · PELiverpool School of Tropical Medicine · GBUniversidad Continental · PE

Funding

Medical Research Council MR/K007467/1Medical Research Council MR/T040165/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

catastrophic costsmeta-analysissystematic reviewtuberculosis

Identifiers

PMID37224318
PMCPMC10170179
OpenAlexW4308354173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.